E
ENSC
Ensysce Biosciences Inc
0.2530
-0.0040-1.56%Closed16:58 07/31 EDT
OPEN/PREV CLOSE0.6307/0.3620
TODAY RANGE0.4602-0.9790
VOL1.64M
MARKET CAP8.06M
52 WEEK RANGE0.2300-2.750
AVG VOL (3M)15.62M
% TURNOVER3,241.36%
TURNOVER32.22K
P/E (TTM)-0.1569
% RANGE143.31%
EPS(TTM)-3.3422
P/E(FORWARD)-0.3427
P/B-14.2861
BVPS-0.0367
DIVIDEND--
P/S0.4734
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.01M
SHARES OUTSTANDING15.37M
NEXT EARNINGS08/11-08/17
FREE FLOAT15.27M
LOT SIZE1
EX-DATE12/06/2024
News
Press Releases
Financial Reports
Profile
Benzinga·19h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·22h ago
Nasdaq Down 50 Points; US Foods Posts Upbeat Earnings
TipRanks·23h ago
Ensysce Acquires Cy Biopharma, Expands Pain Therapy Portfolio
Benzinga·2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
PUBT·07/15 20:16
Ensysce Biosciences COO Jeffrey Millard resigns
TipRanks·07/14 12:30
Ensysce Biosciences awarded $5.3M installment in NIDA funding
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.